精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）

2018-11-01 Equator Network CONSORT

报告规范

社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）

中文标题：

社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）

发布机构：

Equator Network

发布日期：

2018-11-01

简要介绍：

社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cb2c71c0020111fb, title=社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）, enTitle=, guiderFrom=CONSORT, authorId=0, author=, summary=社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）, cover=, journalId=0, articlesId=null, associationId=1954, associationName=Equator Network, associationIntro=equator-network, copyright=0, guiderPublishedTime=Thu Nov 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<p>社会与心理干预治疗随机对照试验报告规范（CONSORT-SPI）</p>, tagList=[TagDto(tagId=20432, tagName=报告规范)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=87, categoryName=论文与基金, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1996, appHits=105, showAppHits=0, pcHits=262, showPcHits=1891, likes=0, shares=10, comments=3, approvalStatus=1, publishedTime=Mon Nov 23 18:02:16 CST 2020, publishedTimeString=2018-11-01, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Mon Nov 23 18:02:10 CST 2020, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 08:11:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=947686, encodeId=612894e686ea, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:57:03 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913667, encodeId=6f8691366ee8, content=好规范！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Jan 04 19:01:57 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901510, encodeId=12c5901510b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b41d5175461, createdName=146e64d2m86暂无昵称, createdTime=Mon Nov 23 18:07:56 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2021-03-12 jyzxjiangqin

    好文章！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=947686, encodeId=612894e686ea, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:57:03 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913667, encodeId=6f8691366ee8, content=好规范！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Jan 04 19:01:57 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901510, encodeId=12c5901510b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b41d5175461, createdName=146e64d2m86暂无昵称, createdTime=Mon Nov 23 18:07:56 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2021-01-04 jyzxjiangqin

    好规范！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=947686, encodeId=612894e686ea, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Mar 12 15:57:03 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913667, encodeId=6f8691366ee8, content=好规范！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Jan 04 19:01:57 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901510, encodeId=12c5901510b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b41d5175461, createdName=146e64d2m86暂无昵称, createdTime=Mon Nov 23 18:07:56 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2020-11-23 146e64d2m86暂无昵称

    很好

    0

相关指南

移动医疗干预措施的临床随机对照试验报告规范（CONSORT-EHEALTH））

Equator Network · 2010-11-05

核心指标集报告规范：COS-STAR 声明

暂未更新 · 2017-10-02

仿真研究的报告规范

暂未更新 · 2016-09-07

探索研究和可行性研究报告规范：CONSORT规范声明扩展

Equator Network · 2017-09-05

中药随机对照临床试验报告规范：CONSORT-CHM 2017

Equator Network · 2017-09-05

社会心理学干预的随机对照临床试验报告规范：CONSORT-SPI 2018扩展

Equator Network · 2019-04-08